Prussian blue analog with separated active sites to catalyze water driven enhanced catalytic treatments.

Wang, Liu-Chun; Chiou, Pei-Yu; Hsu, Ya-Ping; Lee, Chin-Lai; Hung, Chih-Hsuan; Wu, Yi-Hsuan; Wang, Wen-Jyun; Hsieh, Gia-Ling et al. · Nat Commun · 2023

basic_science · Level V

Where this comes from

Abstract

Chemodynamic therapy (CDT) uses the Fenton or Fenton-like reaction to yield toxic ‧OH following H<sub>2</sub>O<sub>2</sub> → ‧OH for tumoral therapy. Unfortunately, H<sub>2</sub>O<sub>2</sub> is often taken from the limited endogenous supply of H<sub>2</sub>O<sub>2</sub> in cancer cells. A water oxidation CoFe Prussian blue (CFPB) nanoframes is presented to provide sustained, external energy-free self-supply of ‧OH from H<sub>2</sub>O to process CDT and/or photothermal therapy (PTT). Unexpectedly, the as-prepared CFPB nanocubes with no near-infrared (NIR) absorption is transformed into CFPB nanoframes with NIR absorption due to the increased Fe<sup>3+</sup>-N ≡ C-Fe<sup>2+</sup> composition through the proposed proton-induced metal replacement reactions. Surprisingly, both the CFPB nanocubes and nanoframes provide for the self-supply of O<sub>2</sub>, H<sub>2</sub>O<sub>2,</sub> and ‧OH from H<sub>2</sub>O, with the nanoframe outperforming in the production of ‧OH. Simulation analysis indicates separated active sites in catalyzation of water oxidation, oxygen reduction, and Fenton-like reactions from CFPB. The liposome-covered CFPB nanoframes prepared for controllable water-driven CDT for male tumoral mice treatments.

Medical subject headings